A Geisinger Health Plan telemonitoring program for heart failure patients significantly reduced hospital readmissions, cut the cost of care for members, improved the efficiency of care managers, and delivered a 3.3 return on investment, according to a new study.
» More
|
ADVERTISEMENT
Qatar International Medical Conference, May 26-28
At The Heart of Healthcare.
More.
|
The FDA has approved filgrastim-sndz (Zarxio, Sandoz), the first biosimilar product, for use in the U.S. » More
|
Acetaminophen is still safer than nonsteroidal anti-inflammatory drugs, but there is concern about its potential for some side effects not usually considered, according to a study published in the Annals of Rheumatic Diseases. » Study results
|
|
Keep in touch with MHE
We value your input. Please send your comments and article ideas to [email protected]. |
|